麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

美國(guó)IRIS International  
Iris集團(tuán)于1979年成立，總部位于洛杉磯北部，并在納斯達(dá)克上市。Iris集團(tuán)旗下包括：Iris診斷、Iris德國(guó)公司、Iris 分子診斷、Iris樣品處理。其中Iris診斷一直致力于開(kāi)發(fā)和研究體外診斷產(chǎn)品，為客戶提供可靠的成本效益解決方案。經(jīng)驗(yàn)豐富的研究人員不斷地開(kāi)發(fā)創(chuàng)新體外診斷技術(shù)以擴(kuò)大最初的產(chǎn)品平臺(tái)，因?yàn)椴恍傅呐Γ琁RIS診斷的數(shù)字影像處理技術(shù)水平在業(yè)界領(lǐng)先，且是尿液分析系統(tǒng)的全球領(lǐng)導(dǎo)者。

    

 


Since 1979, IRIS International, Inc. (NASDAQ: IRIS), has been dedicated to the development and commercialization of innovative medical diagnostics and sample processing products that provide reliable and cost effective solutions for our customers and improved disease management for the patients we serve. IRIS invented and introduced the first automated urinalysis system and in the following years added numerous innovations and improvements, making us the world leader in this technology. Our automated urinalysis systems and sample processing products are today used in hospitals, clinical reference laboratories, veterinary laboratories and research facilities around the world.

Our management and scientists, engineers and senior technical staff with many years of healthcare experience have broadened our initial product platform and have successfully focused on the development and commercialization of innovative in-vitro diagnostics products and solutions, which expand our core imaging and morphology expertise into related markets of oncology, hematology, and microbiology.
Our manufacturing and research activities are conducted through three operating units: Iris Diagnostics Division, Iris Sample Processing Division (formerly StatSpin, Inc.) and Iris Molecular Diagnostics research and development subsidiary. The core competencies in these operating groups include flow imaging technology, morphological pattern recognition, chemistry, ultra-sensitive detection of proteins and rapid and reliable processing of blood and other body fluids. This broad expertise is now being utilized by Iris in the development of a series of "disruptive" technologies, which we believe will introduce a number of new products that will change and sharply advance the fields of urinalysis, hematology, cancer diagnostics and sample processing for human and veterinary applications.

Our 300+ employees take pride in our customers’ contributions to medical science and to improving the lives of patients and are especially aware of the role we play in providing our customers products and services which enable them to carry out their mission to provide better healthcare.